FDA clears Echo-Coat needles

Article

STS Biopolymers of Rush, NY, has received 510(k) clearance for its line of Echo-Coat needles for ultrasound-guided biopsy applications. The needles are coated with a biocompatible polymer material that acts like an ultrasound contrast agent, providing a

STS Biopolymers of Rush, NY, has received 510(k) clearance for its line of Echo-Coat needles for ultrasound-guided biopsy applications. The needles are coated with a biocompatible polymer material that acts like an ultrasound contrast agent, providing a clear picture of the needle under ultrasound guidance, according to the company. STS believes that Echo-Coat will prompt physicians to use ultrasound for guiding biopsy procedures, rather than more expensive technologies like MRI or CT.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.